Synthesis and Encapsulation of Extract with Zeolitic Imidazolate Framework-8 and Their Therapeutic Action Against G and G Drug-Resistant Bacteria
Overview
Affiliations
Infectious diseases caused by bacteria have become a public health issue. Antibiotic therapy for infectious disorders, as well as antibiotic overuse, has resulted in antibiotic-resistant bacterial strains. Zeolitic imidazolate framework-8 (ZIF-8) possesses a wide surface area, high porosity, variable functionality, and potential drug carriers. We have established a clear method for making a nanoscale APE@ZIF-8 nanocomposite agent with outstanding antibacterial activity against methicillin-resistant (MRSA) and cephalosporin-carbapenem-resistant (CCREC). We present a unique approach for encapsulating molecules of extract (APE) with ZIF-8. APE@ZIF-8 has a positive charge. By electrostatic contact with the negatively charged bacterial surface of and , APE@ZIF-8 NPs produce reactive oxygen species (ROS) that damage bacterial cell organelles. As a result, the APE@ZIF-8 nanocomposite offers limitless application potential in the treatment of infectious disorders caused by drug-resistant gram-positive and gram-negative bacteria.
Saif M, Hasan M, Zafar A, Ahmed M, Tariq T, Waqas M Biomedicines. 2023; 11(10).
PMID: 37893205 PMC: 10604899. DOI: 10.3390/biomedicines11102832.